Tumour suppressor genes in chemotherapeutic drug response
Since cancer is one of the leading causes of death worldwide, there is an urgent need to find better treatments. Currently, the use of chemotherapeutics remains the predominant option for cancer therapy. However, one of the major obstacles for successful cancer therapy using these chemotherapeutics...
Main Authors: | Lai, Dulcie, Visser-Grieve, Stacy, Yang, Xiaolong |
---|---|
Format: | Online |
Language: | English |
Published: |
Portland Press Ltd.
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392105/ |
Similar Items
-
Wilms’ tumour and chemotherapeutic access
by: Yasri, Sora, et al.
Published: (2015) -
Chemotherapeutic targeting of myeloid-derived suppressor cells
by: Alizadeh, Darya, et al.
Published: (2014) -
Chemotherapeutic Drugs Interfere with Gene Delivery Mediated by Chitosan-Graft-Poly(ethylenimine)
by: Lai, Wing-Fu, et al.
Published: (2015) -
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
by: Kersten, Kelly, et al.
Published: (2015) -
In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
by: Wilson, A. P., et al.
Published: (1981)